Aurora Investment Counsel’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,298
Closed -$554K 144
2021
Q1
$554K Sell
7,298
-7,411
-50% -$559K 0.41% 106
2020
Q4
$1M Buy
14,709
+44
+0.3% +$2.74K 0.81% 64
2020
Q3
$930K Sell
14,665
-255
-2% -$15.2K 0.77% 73
2020
Q2
$869K Sell
14,920
-590
-4% -$31.7K 0.83% 64
2020
Q1
$611K Sell
15,510
-2,503
-14% -$146K 0.67% 84
2019
Q4
$1.07M Sell
18,013
-10,317
-36% -$555K 0.8% 70
2019
Q3
$1.51M Buy
+28,330
New +$1.45M 0.73% 82

Other funds holding SYNH

Aurora Investment Counsel's SYNH Position: Q2 2021 in Review

Aurora Investment Counsel sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 7,298 shares — an estimated $554K sold.

Aurora Investment Counsel first reported a position in SYNH in Q3 2019 and held it in 7 quarters. The position peaked at $1.51M in Q3 2019. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

  • Aurora Investment Counsel reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Aurora Investment Counsel sold 7,298 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $554K.
  • Aurora Investment Counsel first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2019 and held it in 7 quarters.
  • Aurora Investment Counsel's Syneos Health, Inc. Class A Common Stock position peaked at $1.51M in Q3 2019.
  • 342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Aurora Investment Counsel's 13F filing for Q2 2021, filed 11 Aug 2021.